C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2011
12/29/2011	US20110321191 Control of targeted turnover of key ethylene hormone signaling pathway proteins to modulate ethylene sensitivity in plants
12/29/2011	US20110321190 Method of positive plant selection using sorbitol dehydrogenase
12/29/2011	US20110321189 Polynucleotides and polypeptides involved in post-transcriptional gene silencing
12/29/2011	US20110321187 Plant plastid transformation method
12/29/2011	US20110321186 Modulation of plant cell wall deposition via hdzipi
12/29/2011	US20110321184 Plant with altered inflorescence
12/29/2011	US20110321183 Methods for ligation and uses thereof
12/29/2011	US20110321180 Compositions and methods to generate pilosebaceous units
12/29/2011	US20110321179 Non-human animal model for amyotrophic lateral sclerosis (als) with loss-of-tdp-43 function
12/29/2011	US20110319870 Method for increasing the pool of ngn3+ endocrine progenitor cells and pancreatic endocrine cell mass
12/29/2011	US20110319869 Human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
12/29/2011	US20110319868 Methods, substrates, and systems useful for cell seeding of medical grafts
12/29/2011	US20110319858 Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical compositions and the use thereof
12/29/2011	US20110319602 T2r taste receptors and genes encoding same
12/29/2011	US20110319597 Variant domain antibodies
12/29/2011	US20110319590 Tumour Cell Lines and Uses Thereof
12/29/2011	US20110319493 Histone deacetylases, and uses related thereto
12/29/2011	US20110319480 Method of Inducing and/or Enhancing an Immune Response to Tumor Antigens
12/29/2011	US20110319477 Mutations of the pik3ca gene in human cancers
12/29/2011	US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
12/29/2011	US20110319475 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
12/29/2011	US20110319474 siRNA targeting cyclin-dependent kinase 4 (CDK4)
12/29/2011	US20110319469 SNPs of Apolipoprotein B and Modulation of Their Expression
12/29/2011	US20110319436 Methods and Compositions for Modulating IRE1, SRC, and ABL Activity
12/29/2011	US20110319433 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation
12/29/2011	US20110319386 Neurogenesis by muscarinic receptor modulation
12/29/2011	US20110319360 Method of including apoptosis/Cell death in leukemia cell using a purine nucleoside analogue
12/29/2011	US20110319351 Treating cancer with cardiac glycosides
12/29/2011	US20110319338 Peptides that bind eukaryotic translation initiation factor 4e
12/29/2011	US20110319337 Dominant Negative WNT2 Compositions and Methods of Use
12/29/2011	US20110319336 Selective anticancer chimeric peptide
12/29/2011	US20110319327 Polypeptides Homologous to VEGF and BMP1
12/29/2011	US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1
12/29/2011	US20110319294 Stable, functional chimeric cellobiohydrolase class i enzymes
12/29/2011	US20110319286 System for screening agonists/antagonists of cellular signaling pathways
12/29/2011	US20110319274 Identification of Compounds Modifying a Cellular Response
12/29/2011	US20110318839 Method for enhancing a function of a t cell
12/29/2011	US20110318838 CELL-TYPE SPECIFIC APTAMER-siRNA DELIVERY SYSTEM FOR HIV-1 THERAPY
12/29/2011	US20110318837 Methods and compositions for inducing apoptosis by stimulating er stress
12/29/2011	US20110318836 Method of enriching spermatozoa of mammals bearing x-chromosome or y-chromosome
12/29/2011	US20110318835 Implant Surface Treatment Method Having Tissues Integrated
12/29/2011	US20110318834 Multiple-tumor aberrant growth genes
12/29/2011	US20110318833 Adipose-derived stem cells and laticces
12/29/2011	US20110318832 Human Telomerase Catalytic Subunit
12/29/2011	US20110318831 Chinese hamster apoptosis-related genes
12/29/2011	US20110318830 Compositions and methods for re-programming and re-differentiating cells
12/29/2011	US20110318829 Cell culture container and cell culture method
12/29/2011	US20110318828 Kit for preparation of antigen-specific cytotoxic lymphocytes
12/29/2011	US20110318808 Engineered Plant Cysteine Proteases and Their Uses
12/29/2011	US20110318797 Cytochrome P450s and uses thereof
12/29/2011	US20110318787 Means and methods for modulating notch3 protein expression and/or the coding region of notch3; compositions and use thereof in the treatment of cadasil
12/29/2011	US20110318758 Human monoclonal antibodies and methods for producing the same
12/29/2011	US20110318751 PUMA, A PRO-APOPTOTIC GENE, AS A NOVEL MOLECULAR BIOMARKER FOR TNFalpha-INDUCED HUMAN ISLET DAMAGE
12/29/2011	US20110318749 Method for identifying regulatory t cells
12/29/2011	US20110318745 Compositions and methods for performing hybridizations with separate denaturation of the sample and probe
12/29/2011	US20110318730 Micropatterned co-culture systems as infectious disease analysis platforms
12/29/2011	US20110318725 Cell culture method, cell culture device, method for counting subsject matters to be counted in container and device for counting
12/29/2011	US20110318424 METHODS FOR PROLONGING VIABILITY OF CONE CELLS USING MODULATORS OF THE MAMMALIAN TARGET OF RAPAMYCINE (mTOR)
12/29/2011	US20110318414 Regenerative tissue grafts and methods of making same
12/29/2011	US20110318408 Hla class i a2 tumor associated antigen peptides and vaccine compositions
12/29/2011	US20110318403 Preparation and Use of Pouteria Lucuma Extract
12/29/2011	US20110318389 Human pancreatic beta cell lines for diagnostic of diabetes
12/29/2011	US20110318387 Immunization method using cancer cells
12/29/2011	US20110318380 MHC Multimers in Cancer Vaccines and Immune Monitoring
12/29/2011	US20110318376 Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins
12/29/2011	US20110318374 Spanx-b polypeptides and their use
12/29/2011	US20110318371 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
12/29/2011	US20110318368 Anti-human alpha9 integrin antibody and use thereof
12/29/2011	US20110318367 Novel targets for treatment of hypercholesterolemia
12/29/2011	US20110318362 Novel card proteins involved in cell death regulation
12/29/2011	US20110318361 Anticancer Drug Comprising Inhibitor of Tmprss4
12/29/2011	US20110318357 Methods and compositions based on shiga toxin type 2 protein
12/29/2011	US20110318356 Antibodies Against Tissue Factor Pathway Inhibitor
12/29/2011	US20110318355 Mutant proteins of the f protein of piv-5 and piv-2
12/29/2011	US20110318353 Humanized IL-25 Antibodies
12/29/2011	US20110318349 Dual variable domain immunoglobulins and uses thereof
12/29/2011	US20110318347 Amino acid sequences targeting human cd4, cxcr4, ccr5, tlr4, alphav integrin, beta3-integrin, beta1-integrin, human alpha2-integrin, cd81, sr-bi, claudin-1, claudin-6 and claudin-9, respectively, and neutralizing viral entry
12/29/2011	US20110318339 Anti-dll4 antibodies and uses thereof
12/29/2011	US20110318326 Compositions and Methods
12/29/2011	US20110318319 ACTIVATION and AGGREGATION OF HUMAN PLATELETS AND FORMATION OF PLATELET GELS BY NANOSECOND PULSED ELECTRIC FIELDS
12/29/2011	US20110318318 Anti-apoptotic fusion proteins
12/29/2011	US20110318317 Chinese hamster apoptosis-related genes
12/29/2011	US20110318316 Chinese hamster apoptosis-related genes
12/29/2011	US20110318315 Mesenchymal stem cells and uses therefor
12/29/2011	US20110318314 Mesenchymal stem cells and uses therefor
12/29/2011	US20110318313 Modulation of Splenocytes in Cell Therapy for Traumatic Brain Injury
12/29/2011	US20110318312 Rejuvenation or preservation of germ cells
12/29/2011	US20110318311 Tumor-selective e1a and e1b mutants
12/29/2011	US20110318301 Il-17a/f heterologous polypeptides and therapeutic uses thereof
12/29/2011	US20110318274 Variant of mite allergen and uses thereof
12/29/2011	US20110318264 Methods and compositions for diagnosis and treatment of cancer
12/29/2011	DE102010025294A1 Isolating periodontal stem cells, comprises bringing a tissue sample taken from an alveolar bone and/or cervical gingival margin in a nutrient solution, culturing the tissue sample and removing the vital cells
12/29/2011	CA2840431A1 Compositions and methods for treatment of thrombosis and for prolonging survival of stored platelets
12/29/2011	CA2803814A1 Group culture system and method with helper embryos
12/29/2011	CA2803392A1 Dual variable domain immunoglobulins and uses thereof
12/29/2011	CA2802557A1 Improved crosslinked hyaluronan hydrogels for 3d cell culture
12/29/2011	CA2801348A1 Methods for agrobacterium-mediated transformation of sugar cane
12/28/2011	EP2400021A2 ErbB3 based methods and compositions for treating neoplasms
12/28/2011	EP2400019A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400018A2 In tumours differentially expressed gene products and use of the same

1 ... 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 ... 1827